felodipine has been researched along with Arteriosclerosis, Coronary in 3 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to analyze the effect of felodipine combined with enalapril in the treatment of patients with essential hypertension and coronary artery disease." | 9.51 | Efficacy of felodipine and enalapril in the treatment of essential hypertension with coronary artery disease and the effect on levels of Salusin-β, Apelin, and PON1 gene expression in patients. ( Jin, F; Zhang, J; Zhang, W; Zhou, H, 2022) |
| " In 10 patients with stable coronary artery disease, coronary sinus blood flow and myocardial oxygen supply and consumption (MVO2) were measured both at sinus rhythm and during atrial pacing (30 beats/min above sinus rate), at control and during infusion of felodipine, a vasoselective dihydropyridine." | 7.71 | Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease. ( Kal, JE; Spaan, JA; van Wezel, HB, 2002) |
| "This study aimed to analyze the effect of felodipine combined with enalapril in the treatment of patients with essential hypertension and coronary artery disease." | 5.51 | Efficacy of felodipine and enalapril in the treatment of essential hypertension with coronary artery disease and the effect on levels of Salusin-β, Apelin, and PON1 gene expression in patients. ( Jin, F; Zhang, J; Zhang, W; Zhou, H, 2022) |
| " In 10 patients with stable coronary artery disease, coronary sinus blood flow and myocardial oxygen supply and consumption (MVO2) were measured both at sinus rhythm and during atrial pacing (30 beats/min above sinus rate), at control and during infusion of felodipine, a vasoselective dihydropyridine." | 3.71 | Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease. ( Kal, JE; Spaan, JA; van Wezel, HB, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Zhang, J | 1 |
| Jin, F | 1 |
| Zhou, H | 1 |
| Wong, ND | 1 |
| Teng, W | 1 |
| Abrahamson, D | 1 |
| Willner, R | 1 |
| Henein, N | 1 |
| Franklin, SS | 1 |
| Kashyap, ML | 1 |
| Rosenzweig, B | 1 |
| Kukes, G | 1 |
| Detrano, RC | 1 |
| Kal, JE | 1 |
| Spaan, JA | 1 |
| van Wezel, HB | 1 |
2 trials available for felodipine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Efficacy of felodipine and enalapril in the treatment of essential hypertension with coronary artery disease and the effect on levels of Salusin-β, Apelin, and PON1 gene expression in patients.
Topics: Apelin; Aryldialkylphosphatase; Blood Pressure; Coronary Artery Disease; Enalapril; Essential Hypert | 2022 |
Noninvasive tracking of coronary atherosclerosis by electron beam computed tomography: rationale and design of the Felodipine Atherosclerosis Prevention Study (FAPS).
Topics: Aged; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Coronary Artery Disease; Disease | 1995 |
1 other study available for felodipine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Calcium channel blockade with felodipine does not affect metabolic coronary vasodilation in patients with coronary artery disease.
Topics: Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiac Pacing, Artificial; Coronary Arter | 2002 |